Literature DB >> 19925938

Radiation recall dermatitis induced by erlotinib.

Jean-Noël Dauendorffer, Alain Dupuy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19925938     DOI： 10.1016/j.jaad.2009.04.033

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  8 in total

Review 1.  Radiation recall dermatitis induced by sorafenib : A case study and review of the literature.

Authors:  Sonja Stieb; Oliver Riesterer; Cornelia Brüssow; Bernhard Pestalozzi; Matthias Guckenberger; Stefan Weiler
Journal:  Strahlenther Onkol       Date:  2016-02-23       Impact factor: 3.621

2.  Radiation recall dermatitis after docetaxel chemotherapy. Treatment by antioxidant ointment.

Authors:  Viola Duncker-Rohr; Ulrich Freund; Felix Momm
Journal:  Strahlenther Onkol       Date:  2014-03-11       Impact factor: 3.621

3.  Sorafenib induced radiation recall dermatitis after spine radiosurgery.

Authors:  Jared Robbins; Ira Wollner; Samuel Ryu
Journal:  J Radiosurg SBRT       Date:  2011

4.  Myositis following spine radiosurgery for metastatic disease: a case series.

Authors:  Dennis T Lockney; Angela Y Jia; Eric Lis; Natalie A Lockney; Chengbao Liu; Benjamin Hopkins; Daniel S Higginson; Yoshiya Yamada; Ilya Laufer; Mark Bilsky; Adam M Schmitt
Journal:  J Neurosurg Spine       Date:  2018-01-26

Review 5.  Avoiding Severe Toxicity From Combined BRAF Inhibitor and Radiation Treatment: Consensus Guidelines from the Eastern Cooperative Oncology Group (ECOG).

Authors:  Christopher J Anker; Kenneth F Grossmann; Michael B Atkins; Gita Suneja; Ahmad A Tarhini; John M Kirkwood
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-06-01       Impact factor: 7.038

6.  Predicting treatment related imaging changes (TRICs) after radiosurgery for brain metastases using treatment dose and conformality metrics.

Authors:  B Frazier Taylor; Jonathan P Knisely; Jack M Qian; James B Yu; Veronica L Chiang
Journal:  J Radiosurg SBRT       Date:  2016

7.  Toxic risk of stereotactic body radiotherapy and concurrent helical tomotherapy followed by erlotinib for non-small-cell lung cancer treatment--case report.

Authors:  Chen-Hsi Hsieh; Hou-Tai Chang; Shih-Chiang Lin; Yu-Jen Chen; Li-Ying Wang; Yen-Ping Hsieh; Chien-An Chen; Ngot-Swan Chong; Shoei Long Lin; Chun-Yi Chen; Pei-Wei Shueng
Journal:  BMC Cancer       Date:  2010-12-31       Impact factor: 4.430

8.  Radiation recall dermatitis after treatment with Paclitaxel and Cisplatin.

Authors:  Seung Woo Baek; Young Joon Seo; Jun Sang Kim; Hyo Jin Lee
Journal:  Ann Dermatol       Date:  2012-04-26       Impact factor: 1.444
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.